Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O P Kallioniemi

Showing results (111-120 of 163) with videos related to

Pageof 17
Sort By:
Oncogene|January 18, 2012
CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypesM Niemelä, O Kauko, H Sihto, et al.
Cancer Research|December 16, 2000
Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniquesS L Sallinen, P K Sallinen, H K Haapasalo, et al.
Nature Medicine|July 14, 1998
Tissue microarrays for high-throughput molecular profiling of tumor specimensJ Kononen, L Bubendorf, A Kallioniemi, et al.
Cancer Research|August 17, 2001
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancerA Rökman, T Ikonen, N Mononen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1988
[Flow cytometry of cervical cell changes]M Lehtinen, J Paavonen, A Ylä-Outinen, et al.
The Prostate|February 15, 2001
Genetic changes in familial prostate cancer by comparative genomic hybridizationA Rökman, P A Koivisto, M P Matikainen, et al.
Genomics|March 1, 1995
A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysisT Stokke, C Collins, W L Kuo, et al.
British Journal of Obstetrics and Gynaecology|May 1, 1989
Serum CA 125 in acute pelvic inflammatory diseaseJ Paavonen, A Miettinen, P K Heinonen, et al.
British Journal of Cancer|January 5, 2001
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sitesK Rapakko, M Allinen, K Syrjäkoski, et al.
Cancer Genetics and Cytogenetics|January 13, 2001
Novel findings in gene expression detected in human osteosarcoma by cDNA microarrayM Wolf, W El-Rifai, M Tarkkanen, et al.
Pageof 17

Showing results (111-120 of 163) with videos related to

Sort By:
Pageof 17
Oncogene|January 18, 2012
CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypesM Niemelä, O Kauko, H Sihto, et al.
Cancer Research|December 16, 2000
Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniquesS L Sallinen, P K Sallinen, H K Haapasalo, et al.
Nature Medicine|July 14, 1998
Tissue microarrays for high-throughput molecular profiling of tumor specimensJ Kononen, L Bubendorf, A Kallioniemi, et al.
Cancer Research|August 17, 2001
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancerA Rökman, T Ikonen, N Mononen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1988
[Flow cytometry of cervical cell changes]M Lehtinen, J Paavonen, A Ylä-Outinen, et al.
The Prostate|February 15, 2001
Genetic changes in familial prostate cancer by comparative genomic hybridizationA Rökman, P A Koivisto, M P Matikainen, et al.
Genomics|March 1, 1995
A physical map of chromosome 20 established using fluorescence in situ hybridization and digital image analysisT Stokke, C Collins, W L Kuo, et al.
British Journal of Obstetrics and Gynaecology|May 1, 1989
Serum CA 125 in acute pelvic inflammatory diseaseJ Paavonen, A Miettinen, P K Heinonen, et al.
British Journal of Cancer|January 5, 2001
Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sitesK Rapakko, M Allinen, K Syrjäkoski, et al.
Cancer Genetics and Cytogenetics|January 13, 2001
Novel findings in gene expression detected in human osteosarcoma by cDNA microarrayM Wolf, W El-Rifai, M Tarkkanen, et al.
Pageof 17